These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26485941)

  • 1. [Update on Current Care Guideline: Borderline personality disorder].
    Korkeila J; Kantojärvi L; Koivisto M; Karlsson H; Keinänen M; Lindeman S; Nikkilä H; Stenberg JH; Taiminen T; Jousilahti P; Tuunainen A
    Duodecim; 2015; 131(16):1484-5. PubMed ID: 26485941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medications in the treatment of borderline personality disorder 2006.
    Mercer D
    Curr Psychiatry Rep; 2007 Feb; 9(1):53-62. PubMed ID: 17257515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacological treatment in borderline personality disorder.
    Díaz-Marsá M; González Bardanca S; Tajima K; García-Albea J; Navas M; Carrasco JL
    Actas Esp Psiquiatr; 2008; 36(1):39-49. PubMed ID: 18286399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline personality disorder in the primary care setting.
    Dubovsky AN; Kiefer MM
    Med Clin North Am; 2014 Sep; 98(5):1049-64. PubMed ID: 25134872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF; Calabrese JR
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of pharmacotherapies for borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    CNS Drugs; 2008; 22(8):671-92. PubMed ID: 18601305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of borderline personality disorder.
    Hirschfeld RM
    J Clin Psychiatry; 1997; 58 Suppl 14():48-52; discussion 53. PubMed ID: 9418746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical guidelines for psychotherapy for patients with borderline personality disorder.
    Stone MH
    Psychiatr Clin North Am; 2000 Mar; 23(1):193-210, ix. PubMed ID: 10729939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of personality disorder.
    Bateman AW; Gunderson J; Mulder R
    Lancet; 2015 Feb; 385(9969):735-43. PubMed ID: 25706219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder.
    Hollander E
    J Clin Psychiatry; 1999; 60 Suppl 15():38-44. PubMed ID: 10418814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.
    American Psychiatric Association Practice Guidelines
    Am J Psychiatry; 2001 Oct; 158(10 Suppl):1-52. PubMed ID: 11665545
    [No Abstract]   [Full Text] [Related]  

  • 12. State of the art in the pharmacologic treatment of borderline personality disorder.
    Feurino L; Silk KR
    Curr Psychiatry Rep; 2011 Feb; 13(1):69-75. PubMed ID: 21140245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating three treatments for borderline personality disorder: a multiwave study.
    Clarkin JF; Levy KN; Lenzenweger MF; Kernberg OF
    Am J Psychiatry; 2007 Jun; 164(6):922-8. PubMed ID: 17541052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Borderline Personality Disorder.
    Levy KN; McMain S; Bateman A; Clouthier T
    Psychiatr Clin North Am; 2018 Dec; 41(4):711-728. PubMed ID: 30447734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mentalization based treatment and borderline personality disorder].
    De Oliveira C; Rahioui H; Smadja M; Gorsane MA; Louppe F
    Encephale; 2017 Aug; 43(4):340-345. PubMed ID: 27431343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC; Frankenburg FR; Parachini EA
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transference Focused Psychotherapy for Borderline-Adolescents in a Day Clinic Treatment Program].
    Krischer M; Ponton-Rodriguez T; Gooran GR; Bender S
    Prax Kinderpsychol Kinderpsychiatr; 2017 Jul; 66(6):445-463. PubMed ID: 28701090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?
    Bozzatello P; Rocca P; De Rosa ML; Bellino S
    Expert Opin Pharmacother; 2020 Jan; 21(1):47-61. PubMed ID: 31693423
    [No Abstract]   [Full Text] [Related]  

  • 19. Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial.
    Juul S; Lunn S; Poulsen S; Sørensen P; Salimi M; Jakobsen JC; Bateman A; Simonsen S
    Trials; 2019 Apr; 20(1):196. PubMed ID: 30953536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpersonal psychotherapy for borderline personality disorder.
    Bateman AW
    Clin Psychol Psychother; 2012; 19(2):124-33. PubMed ID: 22344752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.